• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Archives for Malaria Vaccine Initiative

Why not create a vaccine for malaria?

March 12, 2012 By Malaria Q&A Leave a Comment

QUESTION Why not create a vaccine for malaria? ANSWER There are many teams of scientists working hard to try to produce a malaria vaccine. In fact, only last year, the preliminary results of a vaccine trial were published. The vaccine, called RTS,S, has been produced by GlaxoSmithKline and is in the midst of Phase III trials in Africa. The preliminary results showed approximately a … [Read more...]

Filed Under: Malaria Q&A Tagged With: Clinical Trials, financial resources, GlaxoSmithKline, Malaria Vaccine Initiative, morbidity, PATH, pharmaceutical companies, RTS, S, severe malaria, vaccine, vaccine testing

Malaria Vaccine Research

March 9, 2012 By Malaria Q&A Leave a Comment

QUESTION Is there any research to produce anti malaria vaccine, if not, why? ANSWER There are many teams of scientists working hard to try to produce a malaria vaccine. In fact, only last year, the preliminary results of a vaccine trial were published. The vaccine, called RTS,S, has been produced by GlaxoSmithKline and is in the midst of Phase III trials in Africa. The preliminary … [Read more...]

Filed Under: Malaria Q&A Tagged With: GlaxoSmithKline, immune response variation, Malaria Control, malaria research, Malaria Vaccine Initiative, PATH, Phase III trial, Plasmodium, RTS, S, strain variation, vaccine

RTS,S Malaria Vaccine

October 8, 2011 By Malaria Q&A 10 Comments

QUESTION: What information can you provide on this vaccine candidate? ANSWER: RTS,S is a vaccine candidate against Plasmodium falciparum malaria which works by encouraging the host's body to produce antibodies and T cells which diminish the malaria parasite's ability to survive and reproduce in the liver. Produced by GlaxoSmithKline, RTS,S is the first vaccine candidate against … [Read more...]

Filed Under: Malaria Q&A Tagged With: antibody productive, Bill & Melinda Gates Foundation, Gates Foundation, GlaxoSmithKline, Malaria Vaccine, Malaria Vaccine Initiative, PATH Malaria Vaccine Initiative (MVI), Phase III clinical trials, Plasmodium Falciparum, RTSS Vaccine

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2023 Malaria.com ยท Log in